Boston, MA -- (SBWIRE) -- 09/13/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Gray Television, Inc. (NYSE:GTN), Entropic Communications, Inc.(NASDAQ:ENTR), Endocyte, Inc. (NASDAQ:ECYT), New York & Company, Inc. (NYSE:NWY)
Gray Television, Inc. (NYSE:GTN) stock climbed 4.05% to $6.68. The company on Sept. 4 announced the consumer launch of all of its Big Four affiliated channels on the Syncbak app.
As a result, in-market consumers who download the mobile Syncbak app to their tablets or smartphones may now watch their local Gray station during time periods when the channels broadcast their licensed programming. Gray's stations are not offering any content from a Big Four network through Syncbak at this time. With Syncbak's geo-located authentication technology, consumers are only able to view channels while physically located within the television market of the station providing its signal via the Syncbak app.
Is GTN A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Entropic Communications, Inc.(NASDAQ:ENTR) shares gained 4% and closed at $4.16. The company on Sept. 11 announced its Multimedia over Coax Alliance (MoCA®) silicon, the EN2510, powers the Actiontec WCB3000, the latest MoCA-to-Wi-Fi® network adapter in Actiontec'sWhole Home Wireless portfolio. The new device will be on display this week at the IBC Exhibition in Amsterdam at the RAI Convention Center, September 13-17, 2013, at Entropic's Meeting Suite in Hall 13 - Suite G106/G017.
Additionally, the company on Sept. 9 announced the immediate appointment of Matthew Rhodes as senior vice president of Global Marketing. Rhodes is responsible for developing, executing and communicating the Company's overall product vision, strategy and roadmap across all market segments, worldwide. He is based out of Entropic'sSan Diego, Calif., headquarters, and reports directly to Patrick Henry, Entropic's president and CEO.
Is ENTR A Good Buy After The Recent Price Movement? Find Out Here
Endocyte, Inc. (NASDAQ:ECYT) shares gained 3.85% to $15.37. ECYT and Nihon Medi-Physics (NMP) on Sept. 5 announced that they have entered into a license and commercialization agreement. Under the terms of the agreement, Endocyte and NMP will develop and commercialize the companion imaging diagnostic etarfolatide (EC20) for cancer indications in Japan. Approval will be sought from the regulatory authorities to use etarfolatide to select patients who will most likely respond to vintafolide, Endocyte's folate receptor (FR)-targeting SMDC, by identifying tumors that express the FR.
How Should Investors Trade ECYT After The Recent Volatility? Get Free Report Here
New York & Company, Inc. (NYSE:NWY) shares climbed 3.78% and closed at $5.21. The company on August 22 announced results for the second quarter and six months ended August 3, 2013. For the second quarter of fiscal year 2013, net sales were $223.1 million, as compared to $227.7 million for the second quarter of fiscal year 2012. Net loss for the second quarter of fiscal year 2013 was $2.7 million, or $0.04 per diluted share and compares to a net loss of $4.3 million, or $0.07 per diluted share in the prior year second quarter.
How Should Investors Trade NWY After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)